COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 229: Articles 2281-2290  | Next

Is SARS-CoV-2 elimination or mitigation best? Regional and disease characteristics determine the recommended strategy
Martignoni, M. M., Arino, J., Hurford, A. M.
10.1101/2024.02.01.24302169 — Posted: 2024-02-07
Heterogeneity of Diagnosis and Documentation of Post-COVID Conditions in Primary Care: A Machine Learning Analysis
Hendrix, N., Parikh, R. V., Taskier, M., Walter, G., Rochlin, I., Saydeh, S., Koumans, E. H., Rincon-Guevara, O., Rehkopf, D. H., Phillips, R. L.
10.1101/2024.02.07.24302451 — Posted: 2024-02-07
SARS-CoV-2 infection elucidates unique features of pregnancy-specific immunity
Oh, D. S., Kim, E., Lu, G., Normand, R., Shook, L. L., Lyall, A., Jasset, O., Demidkin, S., Gilbert, E., Kim, J., Akinwunmi, B., Tantivit, J., Tirard, A., Arnold, B. Y., Slowikowski, K., MGH COVID-19 Collection & Processing Team, , Goldberg, M. B., Filbin, M. R., Hacohen, N., Nguyen, L. H., Chan, A. T., Yu, X. G., Li, J. Z., Yonker, L., Fasano, A., Perlis, R. H., Pasternak, O., Gray, K. J., Choi, G. B., Drew, D. A., Sen, P., Villani, A.-C., Edlow, A. G., Huh, J. R.
10.1101/2024.02.05.24301794 — Posted: 2024-02-07
Acute kidney injury outcomes of COVID-19 confirmed patients in a Philippine tertiary hospital: A retrospective study
Sayson, J., Kalaw, R., Ordona, B. E., Lim, M. E.
10.1101/2024.02.05.24302369 — Posted: 2024-02-06
SARS-CoV-2 booster vaccine dose significantly extends humoral immune response half-life beyond the primary series
Korosec, C. S., Dick, D. W., Moyles, I., Watmough, J.
10.1101/2024.02.06.24302345 — Posted: 2024-02-06
Increased pediatric RSV case counts following the emergence of SARS-CoV-2 are attributable to increased testing
Petros, B. A., Milliren, C. E., Sabeti, P. C., Ozonoff, A.
10.1101/2024.02.06.24302387 — Posted: 2024-02-06
Short- and long-term effects of imatinib in patients hospitalised for COVID-19 infection: A randomised controlled trial
Halme, A. L. E., Laakkonen, S., Rutanen, J., Nevalainen, O. P. O., Sinisalo, M., Horstia, S., Mustonen, J. M. J., Pourjamal, N., Vanhanen, A., Solidarity Finland Investigators, , Rosberg, T., Renner, A., Perola, M., Paukkeri, E.-L., Patovirta, R.-L., Parkkila, S., Paajanen, J., Nykanen, T., Mantyla, J., Myllarniemi, M., Mattila, T., Leinonen, M., Kulmasu, A., Kuutti, P., Kuitunen, I., Kreivi, H.-R., Kilpelainen, T. P., Kauma, H., Kalliala, I. E. J., Jarvinen, P., Hankkio, R., Hammaren, T., Feuth, T., Ansakorpi, H., Ala-Karvia, R., Guyatt, G. H., Tikkinen, K. A. O.
10.1101/2024.02.02.24302227 — Posted: 2024-02-06
Clinical evaluation of the Roche distributed SD Biosensor SARS-CoV-2 & Flu A/B Rapid Antigen Test amongst mild symptomatic people during the 2022/2023 winter season.
Igloi, Z., Velzing, J., Koopmans, M., Molenkamp, R.
10.1101/2024.02.05.24302338 — Posted: 2024-02-06
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology
Banga, J., Petros, B. A., Dai, E. Y., Leonelli, A. T., Dobbins, S. T., Messer, K. S., Nathanson, A. B., Capone, A. A., Littlehale, N. A., Appiah-Danquah, V., Dim, S., Moreno, G. K., Crowther, M., Lee, K. A., DeRuff, K. C., MacInnis, B. L., Springer, M., Sabeti, P. C., Stephenson, K. E.
10.1101/2024.02.05.24302348 — Posted: 2024-02-06
SSRI Use During Acute COVID-19 Infection Associated with Lower Risk of Long COVID Among Patients with Depression
Butzin-Dozier, Z., Ji, Y., Deshpande, S., Hurwitz, E., Coyle, J., Shi, J., Mertens, A. N., van der Laan, M., Colford, J. M., Patel, R. C., Hubbard, A., on behalf of the National COVID Cohort Collaborative
10.1101/2024.02.05.24302352 — Posted: 2024-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).